Advocacy Actions
Meeting with CFDA Center for Medical Device Evaluation
Meeting with new head of CMDE and raised key concerns of the industry
Read moreComments on CFDA's Draft "Catalogue of IVD Products Exempt from Clinical Trials"
The Healthcare Equipment (HCE) Working Group submitted Comments on the CFDA's Draft "Catalogue of IVD Products Exempt from Clinical Trials"
Read moreComments on the CFDA's draft Third Catalog of Medical Devices Exempt from Clinical Trials
The Healthcare Equipment Working Group Submitted Comments on the CFDA's draft Third Catalog of Medical Devices Exempt from Clinical Trials
Read moreComments to the Legislative Affairs Commission of National People's Congress on the Standardisation Law Revised Draft
The European Chamber submitted consolidated comments to the Legislative Affairs Commission of National People's Congress on the Standardisation Law Revised Draft.
Read moreMeeting with Beijing Investment Promotion Bureau
Mr Zhang Tong, Deputy Director General of Beijing Investment Promotion Bureau or known as Invest Beijing paid a visit to the Chamber Beijing office and had a meeting with some members and working group representatives.
Read more2nd Sweden-China Health Forum
The NHFPC and the Swedish Ministry of Health hold a one-day seminar on non-communicable diseases care with the two focus areas health insurance of respiratory diseases and experience exchange of respiratory disease prevention and control.
Read moreRoundtable on Innovation of Medical Devices
Officials from NHFPC, CMDE of CFDA, and clinical experts from medical institutes / hospitals, and representatives from associated industry organizations, and EUCCC were invited by the organizer, to have a roundtable meeting on innovation of medical devices.
Read moreComments to the Jiangsu HFPC's draft Implementation Plan of the “Two-Invoice System“ for Medical Devices
The Healthcare Equipment Working Group submitted Comments to the Jiangsu Health and Family Planning Commission (HFPC) on the draft Implementation Plan of the “Two-Invoice System“ for Drug Procurement by Public Hospitals.
Comments to CFDA on Doc. #52-55 encouraging innovative new drugs and devices
Comments on CFDA on the documents #52 – 55 (Encourage Innovative new Drugs and Pharmaceutical Products) was submitted to CFDA
Read moreComments to the Taizhou HFPC's "Regulations on Purchasing and Distribution of Standard Medical Devices"
The Healthcare Equipment Working Group submitted comments to the draft "Regulations on Purchasing and Distribution of Standard Medical Devices", published for public consultation by the Health and Family Planning Commission of Taizhou City.
Read more